National Center for Injury Prevention and Control/ Initial Review Group, (NCIPC/IRG), 12740 [E8-4643]

Download as PDF 12740 Federal Register / Vol. 73, No. 47 / Monday, March 10, 2008 / Notices Dated: February 29, 2008. Maryam I. Daneshvar, Acting Reports Clearance Officer, Centers for Disease Control and Prevention. [FR Doc. E8–4651 Filed 3–7–08; 8:45 am] DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention BILLING CODE 4163–18–P Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): ‘‘Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Medically Attended Outcomes’’, Funding Opportunity Announcement (FOA) IP08–001 and ‘‘Influenza Vaccine Efficacy in Tropical and Developing Countries’’, FOA IP08–002 National Center for Injury Prevention and Control/ Initial Review Group, (NCIPC/IRG) DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Clinical Laboratory Improvement Advisory Committee: Notice of Charter Renewal This gives notice under the Federal Advisory Committee Act (Pub. L. 92– 463) of October 6, 1972, that the Clinical Laboratory Improvement Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services, has been renewed for a 2-year period through February 19, 2010. For information, contact Thomas Hearn, PhD, Executive Secretary, Clinical Laboratory Improvement Advisory Committee, Centers for Disease Control and Prevention, Department of Health and Human Services, 1600 Clifton Road, NE., Mailstop C12, Atlanta, Georgia 30333, telephone 404/718–1048 or fax 404/ 639–3039. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Dated: February 29, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–4719 Filed 3–7–08; 8:45 am] In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the aforementioned meeting. Time and Date: 9 a.m.–5 p.m., April 30, 2008 (Closed). Place: Centers for Disease Control and Prevention, Atlanta, GA. Status: The meeting will be closed to the public in accordance with provisions set forth in section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92–463. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of ‘‘Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory Confirmed Medically Attended Outcomes’’, Funding Opportunity Announcement (FOA) IP08–001 and ‘‘Influenza Vaccine Efficacy in Tropical and Developing Countries’’, FOA IP08–002.’’ For Further Information Contact: Christine J. Morrison, Ph.D., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone: (404) 639–3098. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 29, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–4754 Filed 3–7–08; 8:45 am] BILLING CODE 4163–18–P Times and Dates: 1 p.m.–1:30 p.m., March 26, 2008 (Open) 1:30 p.m.–5 p.m., March 26, 2008 (Closed) Place: Teleconference. Status: Portions of the meetings will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Section 10(d) of Public Law 92–463. Purpose: This group is charged with providing advice and guidance to the Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control. Matters To Be Discussed: The meeting will include the review, discussion, and evaluation of cooperative agreement applications submitted in response to Fiscal Year 2008 Requests for Applications related to the following individual research announcement: CE08–007, Assessing the Effects of Interpersonal Violence Prevention on Suicide. Agenda items are subject to change as priorities dictate. For Further Information Contact: J. Felix Rogers, Ph.D., M.P.H., Telephone (770) 488– 4334, CDC, 4770 Buford Highway, NE., M/S F62, Atlanta, Georgia 30341–3724. The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: February 29, 2008. Elaine L. Baker, Director, Management Analysis and Services Office Centers for Disease Control and Prevention. [FR Doc. E8–4643 Filed 3–7–08; 8:45 am] BILLING CODE 4163–18–P pwalker on PROD1PC71 with NOTICES In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned review group: BILLING CODE 4163–18–P VerDate Aug<31>2005 16:39 Mar 07, 2008 Jkt 214001 PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\10MRN1.SGM 10MRN1

Agencies

[Federal Register Volume 73, Number 47 (Monday, March 10, 2008)]
[Notices]
[Page 12740]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-4643]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


National Center for Injury Prevention and Control/ Initial Review 
Group, (NCIPC/IRG)

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), announces the following meeting of the aforementioned 
review group:

    Times and Dates:

    1 p.m.-1:30 p.m., March 26, 2008 (Open)
    1:30 p.m.-5 p.m., March 26, 2008 (Closed)
    Place: Teleconference.
    Status: Portions of the meetings will be closed to the public in 
accordance with provisions set forth in Section 552b(c)(4) and (6), 
Title 5, U.S.C., and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Section 10(d) of 
Public Law 92-463.
    Purpose: This group is charged with providing advice and 
guidance to the Secretary, Department of Health and Human Services, 
and the Director, CDC, concerning the scientific and technical merit 
of grant and cooperative agreement applications received from 
academic institutions and other public and private profit and 
nonprofit organizations, including State and local government 
agencies, to conduct specific injury research that focuses on 
prevention and control.
    Matters To Be Discussed: The meeting will include the review, 
discussion, and evaluation of cooperative agreement applications 
submitted in response to Fiscal Year 2008 Requests for Applications 
related to the following individual research announcement: CE08-007, 
Assessing the Effects of Interpersonal Violence Prevention on 
Suicide.
    Agenda items are subject to change as priorities dictate.
    For Further Information Contact: J. Felix Rogers, Ph.D., M.P.H., 
Telephone (770) 488-4334, CDC, 4770 Buford Highway, NE., M/S F62, 
Atlanta, Georgia 30341-3724.
    The Director, Management Analysis and Services Office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: February 29, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention.
 [FR Doc. E8-4643 Filed 3-7-08; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.